Why the study?
Does phenylephrine infusion increase high-frequency power of R-R variability in normal subjects?
Does phenylephrine infusion increase high-frequency power of R-R variability in normal subjects?
High-frequency power of R-R variability accurately reflects increases in vagal modulation during phenylephrine-induced baroreceptor activation, contradicting a previous study.
Answers are grounded in this paper and cite their sources.
Phenylephrine boosts HF power as vagal marker in normals; supports consensus but leaves open clinical translation.
High-frequency power, measured from power spectral analysis of R-R variability, reflects vagal modulation of the sinus node. Unexpectedly, a recent study reported a decrease in high-frequency power during the infusion of phenylephrine despite a prolongation of R-R intervals, indicating an increase in vagal activity. To better define the limitations of high-frequency power to quantify vagal modulation, we measured high-frequency power during the infusion of phenylephrine (0.4, 0.8, and 1.2 micrograms.kg-1.min-1) into 10 normal subjects. We found increasing doses of phenylephrine produced progressive increases in systolic blood pressure from 118 +/- 4 to 129 +/- 5 mmHg (P < 0.005), R-R intervals from 881 +/- 44 to 1,274 +/- 69 ms (P < 0.0001), and the logarithm of high-frequency power from 5.83 +/- 0.22 to 7.73 +/- 0.24 ln(ms2) (P < 0.0001). The conclusion was high-frequency power increases with increasing doses of phenylephrine. These data strongly support the ability of high-frequency power to detect an increase in vagal modulation during baroreceptor activation from an increase in systolic blood pressure with the infusion of phenylephrine.
No takes yet. Share an insight, caveat, or question.
Bloomfield et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: